🇺🇸 LLY — Eli Lilly and Company

Healthcare Compra
← Volver

Precio actual

1.149,36 USD

Máx. histórico

1.292,65

16 días

Split 2:1 del 16/10/1997

Caída desde máximo

-11,08%

Rango 52 semanas

712,05 – 1.292,65

Variación hoy

-0,88%

Cierre anterior

1.159,60

Rango de hoy

1.138,31 – 1.158,43

Volumen hoy

2.159.931

Información
Nombre completo
Eli Lilly and Company
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
50.000
PER ⓘ
38,61 (puede no estar actualizado)
Dividend yield
0,60% (puede no estar actualizado)
Precio objetivo analistas
1.315,56 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 3 días
Sobre la empresa

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss for severe atopic dermatitis; Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Omvoh for ulcerative colitis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. Further, it provides Emgality for migraine prevention and episodic cluster headache, as well as Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron; strategic collaboration with Ascidian Therapeutics for development of therapies for undisclosed monogenic kidney diseases; and BioArctic AB (publ) for new treatment. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Dividendos repartidos Total últimos 12 meses: 6,6900 USD · Yield: 0,58%
Fecha de pago Importe por participación
06/11/1992 0,1375 USD
10/08/1992 0,1375 USD
11/05/1992 0,1375 USD
10/02/1992 0,1375 USD
08/11/1991 0,1250 USD
09/08/1991 0,1250 USD
09/05/1991 0,1250 USD
07/02/1991 0,1250 USD
08/11/1990 0,1025 USD
09/08/1990 0,1025 USD
09/05/1990 0,1025 USD
09/02/1990 0,1025 USD
09/11/1989 0,0843 USD
09/08/1989 0,0843 USD
09/05/1989 0,0843 USD
Splits Registrados en el histórico de precios
Fecha Ratio
16/10/1997 2:1
21/12/1995 2:1
01/05/1989 2:1
30/01/1986 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/04/2006 53,25 53,35 52,88 53,27 -0,28% 0,88% 2.174.200
12/04/2006 52,78 53,61 52,50 53,42 +0,60% 2,10% 3.200.100
11/04/2006 53,49 53,50 52,65 53,10 -0,51% 1,59% 4.454.100
10/04/2006 53,60 53,73 53,06 53,37 -0,32% 1,25% 2.486.700
07/04/2006 54,25 54,41 53,36 53,54 -1,73% 1,94% 4.515.400
06/04/2006 55,00 55,20 54,27 54,48 -0,71% 1,69% 3.791.500
05/04/2006 55,41 55,63 54,66 54,87 -0,53% 1,75% 4.407.100
04/04/2006 55,20 55,42 54,64 55,16 -0,14% 1,41% 5.302.500
03/04/2006 55,65 55,90 55,06 55,24 -0,11% 1,51% 3.928.500
31/03/2006 55,90 56,27 55,20 55,30 -1,34% 1,91% 5.139.100
30/03/2006 55,90 56,70 55,64 56,05 -0,48% 1,90% 3.525.300
29/03/2006 56,08 56,32 55,25 56,32 -0,11% 1,91% 6.317.400
28/03/2006 57,19 57,70 56,00 56,38 -3,90% 2,97% 7.624.500
27/03/2006 58,86 58,97 58,21 58,67 -0,32% 1,29% 3.190.700
24/03/2006 58,45 59,24 58,32 58,86 +1,41% 1,57% 4.281.800
23/03/2006 58,28 58,37 57,60 58,04 -0,77% 1,32% 2.720.900
22/03/2006 57,75 58,68 57,59 58,49 +2,06% 1,89% 3.656.800
21/03/2006 57,70 57,85 57,26 57,31 -0,19% 1,02% 2.847.700
20/03/2006 57,79 57,97 57,36 57,42 +0,58% 1,06% 3.008.100
17/03/2006 57,52 57,55 56,94 57,09 -0,24% 1,06% 3.432.600
16/03/2006 57,22 57,38 56,78 57,23 +0,46% 1,05% 2.526.400
15/03/2006 57,30 57,40 56,45 56,97 -1,01% 1,66% 4.035.800
14/03/2006 57,07 57,72 56,85 57,55 +0,54% 1,52% 3.543.700
13/03/2006 57,53 57,65 57,08 57,24 -0,02% 0,99% 2.406.300
10/03/2006 57,46 57,60 56,90 57,25 +0,30% 1,22% 3.524.300
09/03/2006 57,90 57,90 56,86 57,08 -0,49% 1,80% 3.366.400
08/03/2006 56,50 57,51 56,47 57,36 +1,32% 1,84% 4.251.000
07/03/2006 56,49 56,99 56,40 56,61 +0,21% 1,04% 3.413.200
06/03/2006 56,00 56,80 55,78 56,49 +1,40% 1,82% 4.022.900
03/03/2006 55,50 56,37 55,40 55,71 -0,07% 1,75% 2.319.800